about
The scientific foundation for tobacco harm reduction, 2006-2011Use of smokeless tobacco and risk of cardiovascular disease: A systematic review and meta-analysisRisk of incident cardiovascular disease among users of smokeless tobacco in the Atherosclerosis Risk in Communities (ARIC) study.Snus (Swedish smokeless tobacco) use and risk of stroke: pooled analyses of incidence and survival.Snus user identity and addiction: a Swedish focus group study on adolescents.Clinical, lifestyle, socioeconomic determinants and rate of asymptomatic intracranial atherosclerosis in stroke free Pakistanis.Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis.Trends in smokeless tobacco use in the us workforce: 1987-2005.Changing patterns of tobacco use in a middle-aged population: the role of snus, gender, age, and education.Distribution, Severity and Radiologic Features of Intracranial Stenosis in Asymptomatic Pakistanis.Global burden of disease due to smokeless tobacco consumption in adults: analysis of data from 113 countries.Smokeless Tobacco and Stroke - A Clinico-epidemiological Follow-up Study in A Tertiary Care Hospital.Association of exclusive smokeless tobacco consumption with hypertension in an adult male rural population of India.Tobacco and the pediatric chronic kidney disease population.Association of blood pressure and cardiovascular mortality in India: Mumbai cohort study.The acute effects of smokeless tobacco on central aortic blood pressure and wave reflection characteristics.Smokeless tobacco use among rural women in NE Alabama.Snus use and cardiovascular risk factors in the general population: the HUNT3 study.Assessment of smokeless tobacco use in the history and physical examination by primary healthcare providers.Predictors of Hypertension among Nonpregnant Females Attending Health Promotion Clinic with Special Emphasis on Smokeless Tobacco: A Cross-Sectional Study.Comprehensive review of cardiovascular toxicity of drugs and related agents.Tobacco industry consumer research on smokeless tobacco users and product development.Smokeless tobacco use and circulatory disease risk: a systematic review and meta-analysisA systematic review on association between smokeless tobacco & cardiovascular diseases
P2860
Q27497414-50F11FB3-7A80-41C4-95AB-727989BF0E18Q28276089-F4BC6218-C116-48B2-8D66-6423C02B1304Q34179642-7B862705-71A7-4046-B95B-FAD64D4ADAFEQ34405020-E3167F99-77FE-49DD-8C9B-657F05C22889Q34475568-A8342D8B-F204-425C-B93F-F8EFD2167EA9Q34538682-DFA57123-2CEC-4C2C-BAAF-DB2E12117E42Q34998151-90A10ABA-B6C5-4699-856D-CA3964748C41Q35054577-D32C44AC-1BBF-4090-8BF0-88EF6A3C008EQ35056113-F07FFB5D-CC23-4F31-B123-04D14B9D8603Q35073640-50C07B56-8113-46BC-AEA1-73485CB14756Q35747211-01F99442-44F4-4F9A-8266-B0627ABCFB33Q37435551-69818907-68B0-49EC-A7C6-94662E503C8CQ37463021-AEF29208-A480-430F-8BBC-1B648028038BQ38217063-C980AB74-24EC-4F48-9467-A8EE0023C1B7Q39894153-91E50754-7F86-4014-83B7-D66D9E9E2F89Q41840987-192F5DF8-6BCC-4E8B-8203-0D1DEB6D3E9FQ44579619-EEAD80C4-EBDC-46D0-85E4-F1AA21AE6DA2Q45732692-81A5B9F1-BD17-4713-B5B5-9D8F998F3930Q46827858-FA2E6A1A-513D-4A8E-9A4F-5A4B8AF8C3D0Q47271587-187AF5C1-8761-41D5-91CA-A6BBDE24E284Q47556269-EA7E04B6-6508-46BF-9ACC-A6717E9B1C23Q53089544-15DDED61-1CDC-4505-BB42-C519810CB128Q57921824-E356F271-F0E4-45E5-94AC-112037E88C03Q57938337-216A3D0D-6CDF-4C42-82EF-2127D0A9464A
P2860
description
im November 2008 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2008
@uk
name
Smokeless Tobacco and the Risk of Stroke
@en
Smokeless Tobacco and the Risk of Stroke
@nl
type
label
Smokeless Tobacco and the Risk of Stroke
@en
Smokeless Tobacco and the Risk of Stroke
@nl
prefLabel
Smokeless Tobacco and the Risk of Stroke
@en
Smokeless Tobacco and the Risk of Stroke
@nl
P2093
P1433
P1476
Smokeless Tobacco and the Risk of Stroke
@en
P2093
Andreas Terent
Maria-Pia Hergens
P304
P356
10.1097/EDE.0B013E3181878B33
P577
2008-11-01T00:00:00Z